ANEB vs LVS · $15.3M cap vs P/E 28, rev $6.74B
Anebulo Pharmaceuticals Inc (ANEB) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
ANEB currently screens at market cap $15.3M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the ANEB and LVS stock pages for the full models.
Not investment advice.